36
Participants
Start Date
November 30, 2012
Primary Completion Date
March 31, 2013
Study Completion Date
May 31, 2013
LCP-Tacro tablets
Tacrolimus
Prograf
Tacrolimus
Clinical Investigative Site 00006, New York
Clinical Investigative Site 000011, Buffalo
Clinical Investigative Site 00003, Philadelphia
Clinical Investigative Site 00001, Charlottesville
Clinical Investigative Site 000002, Tampa
Clinical Investigative Site 00008, Cleveland
Clinical Investigative Site 000009, Ann Arbor
Clinical Investigative Site 000013, Dallas
Clinical Investigative Site 00004, Aurora
Clinical Investigative Site 000015, San Diego
Clinical Investigative Site 000012, San Francisco
Clinical Investigative Site 000005, Lexington
Clinical Investigative Site 000010, Livingston
Lead Sponsor
Veloxis Pharmaceuticals
INDUSTRY